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Available online 16 June 2016Traumatic brain injury (TBI), ranging frommild concussion to severe penetrating wounds, can involve brain re-
gions that contain damaged or lost synapses in the absence of neuronal death. These affected regions signiﬁcantly
contribute to sensory, motor and/or cognitive deﬁcits. Thus, studying the mechanisms responsible for synaptic
instability and dysfunction is important for protecting the nervous system from the consequences of progressive
TBI. Our controlled cortical impact (CCI) injury produces ~20% loss of synapses andmild changes in synaptic pro-
tein levels in the CA3-CA1 hippocampus without neuronal losses. These synaptic changes are associated with
functional deﬁcits, indicated by N50% loss in synaptic plasticity and impaired learning behavior. We show that
the receptor tyrosine kinase EphB3 participates in CCI injury-induced synaptic damage, where EphB3−/−mice
show preserved long-term potentiation and hippocampal-dependent learning behavior as compared with wild
type (WT) injured mice. Improved synaptic function in the absence of EphB3 results from attenuation in CCI in-
jury-induced synaptic losses and reduced D-serine levels compared with WT injured mice. Together, these ﬁnd-
ings suggest that EphB3 signaling plays a deleterious role in synaptic stability and plasticity after TBI.






Traumatic brain injury1. Introduction
Every year millions of people suffer the devastating consequences of
a traumatic brain injury (TBI) (Centers for Disease Control and
Prevention (CDC), 2013; Hyder et al., 2007). TBI is a complex disorder
that leads to profounddeﬁcits in neurological function as a result of pro-
gressive pathological events. TBI can be categorized as an open or closed
head injury ranging frommild to severe pathology. At the site of impact,
moderate to severe brain injuries usually include vascular damage, cell
loss, axonal and synaptic damage; however, synaptic dysfunction in
the absence of cell loss has also been observed in more distal regions
(Kotapka et al., 1991; Lowenstein et al., 1992).Moreover, synaptic dam-
age is thought to be a major contributor to chronic neurological symp-
toms following mild concussive injuries (Harish et al., 2015; Merlo et
al., 2014). For this reason, it is important to understand themechanisms
that regulate synaptic stability and plasticity in the traumatic injured
brain.
Learning andmemory deﬁcits are commonly observed impairments
following TBI (Lyeth et al., 1990; Schwarzbach et al., 2006;Witgen et al.,re Paralysis, The University of
A.
ect.com).
. This is an open access article under2005). Consolidation of short- and long-term memory is attributed to
activity-dependent changes in synaptic strength (i.e. synaptic plasticity)
in the hippocampus. NMDAR activation is critical for synaptic plasticity,
as its activation is known to regulate glutamatergic receptor density in
the post-synaptic membrane, bouton size, and synaptic strength
(Adams et al., 2001; Hardingham and Bading, 2010; Hunt and Castillo,
2012). Recently, D-serine has been shown to function as the endogenous
co-agonist for NMDARs, and together with glutamate is essential for
synaptic plasticity, learning and memory (Balu et al., 2014; Han et al.,
2015; Mothet et al., 2000; Wolosker et al., 1999a). D-serine is synthe-
sized through the racemization of L-serine by the enzyme serine
racemase (Wolosker et al., 1999b), though the mechanisms that regu-
late D-serine conversion and release after TBI have yet to be explored.
What is known is that excessive activation of NMDARs is thought to
play a key role in TBI pathology, and underlies excitotoxic cell death
(Faden et al., 1989; Hardingham et al., 2002). It is less clear whether
sub-excitotoxic activation of NMDAR by D-serine after TBI can lead to
synaptic damage.
Receptor tyrosine kinases are also associated with synaptic mem-
branes and play important roles in regulating synaptic formation and
function. In particular, Eph receptors (Ephs) have been shown to stabi-
lize post-synaptic densities, regulate excitatory synaptic numbers, glu-
tamate receptor transport, and synaptic plasticity (Antion et al., 2010;
Grunwald et al., 2004; Henkemeyer et al., 2003; Hruska et al., 2015;the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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are membrane bound and can elicit bidirectional signals upon interac-
tions of pre- and post-synaptic membranes (Aoto and Chen, 2007;
Klein, 2009; Pasquale, 2008). Astrocytes can also interact with neuronal
components of the synapse inwhat is known as the tripartite synapse to
regulate synapse formation and plasticity (Halassa et al., 2007; Perea et
al., 2009). Astroglial release of glutamate and D-serine can alter synaptic
function, where gliotransmitter levels in the synapse can ﬁne-tune ex-
citatory postsynaptic potentials (Araque et al., 2014; Gundersen et al.,
2015; Halassa et al., 2007). Moreover, ephrinB3 interaction with
EphB3 and EphA4 in astrocytes is known to inﬂuence hippocampal syn-
aptic plasticity through regulation of D-serine synthesis and release
(Zhuang et al., 2010). It is therefore important to understand the role
of Eph-mediated signaling events following TBI, speciﬁcally the contri-
bution to D-serine release and synaptic function.
Our ﬁndings suggest that elevated levels of D-serine after TBI may
contribute to progressive CNS pathology.We also show that EphB3 neg-
atively regulates excitatory glutamatergic synaptic stability and plastic-
ity after moderate TBI, as observed by decreased D-serine levels,
improved synaptic stability and enhanced long-term potentiation in
the absence of EphB3.
2. Materials & methods
2.1. Animals
EphB3 knockout (EphB3−/−) mutant mice were bred on a C57Bl/6
background as previously described (Henkemeyer et al., 1996; Orioli
et al., 1996). All procedures were performed on both wild type (WT)
and EphB3−/−male mice 2–4 months of age and approved by the Uni-
versity of Miami Institutional Animal Care and Use Committee.
2.2. Controlled cortical impact (CCI) injury
Mice were initially anesthetized with a ketamine/xylazine cocktail
and placed on a heating pad. Mice were placed in a stereotaxic frame,
where they remained until the end of the procedure. The head was
shaved and the skull was exposed through a skin incision. A 5 mm cra-
niotomy was made over the right parieto-temporal cortex without
disturbing the dura, with the epicenter coordinates at bregma:
−2.0 mm; lateral:−2.5 mm. Mice were then subjected to a moderate
CCI at a velocity of 4 m/s, 0.50 mm depth and 150 ms duration using
an eCCI-6.0 device (Custom Design & Fabrication, Richmond, VA). The
CCI consists of a pressurizedmetal piston delivering a blow at the afore-
mentioned parameters directly onto the dura of the brain producing
mechanical strain forces similar to those observed in human TBI
(Osier et al., 2015). Following the impact, the skin was closed using 5-
0 Vicryl synthetic absorbent sutures, and animals were placed into a
clean cage on a heating pad until recovery from anesthesia. Mice re-
ceived 0.9% saline and analgesic (Buprenorphine) injections and moni-
tored bi-daily for one week.
2.3. Stereological cell and neuronal counts
Mice were anesthetized and perfused with 0.1 M phosphate buffer
and 4% paraformaldehyde (PFA). Brains were dissected and serially
cryo-sectioned (Leica CM 1900, Leica Biosystems Inc., Buffalo Grove,
IL) at 15 μm/section from bregma−1.4 to−2.2 for a total tissue thick-
ness ~1500 μm. For total hippocampal cell counts and regional volumet-
ric analysis, hematoxylin and eosin staining was performed on serial
sections. Micro Bright Field StereoInvestigator software package (MBF
Bioscience, Williston, VT) was used to contour the dentate gyrus,
hilus, CA3 and CA1 areas at 10× magniﬁcation. After contouring, a
grid of 100×100 μm2was placed over each region of interest and hema-
toxylin-stained nuclei within a random sampling box of 50 × 50 μm2
was counted using the optical fractionator at 63× magniﬁcation forunbiased determination of cell number. Investigators were blind to ex-
perimental group. For neuronal counts, neuronal labeling with NeuN
antibody (Cell Signaling, Beverly, MA) and DAPI was performed on seri-
al sections. Randomized images of each hippocampal region were ac-
quired at 40× magniﬁcation using an Olympus BX50 microscope.
ImageJ software was utilized to quantify DAPI-positive and NeuN-posi-
tive cells within the dentate granule cell, CA1 and CA3 pyramidal cell
layers. Investigators were blind to experimental group.
2.4. Transmission electron microscopy (TEM)
Mice were anesthetized and perfused with 2% PFA/2% glutaralde-
hyde in 0.1 M phosphate buffer. Brains were dissected, embedded in
chicken albumin agar and cut into 500 μmsections using amotorized vi-
brating-blade microtome (Leica VT1000s, Leica Biosystems Inc., Buffalo
Grove, IL). CA1 hippocampal regions were dissected, cut into 1 mm2
pieces, and further post-ﬁxed with 3% EM grade glutaraldehyde. Ultra-
thin tissue sections were stained with conventional osmium-uranium-
lead method containing 1% ethanolic phosphotungstic acid (EPTA).
The CA1 hippocampus was visualized using a Philips CM-10 TEM oper-
ating at 80 kV. Sections were placed on a grid and non-overlapping ran-
domized photographs (N20/section) were taken throughout the
entirety of CA1 stratum radiatum. Photographs were digitized, and an
investigator blinded to experimental group quantiﬁed synapses manu-
ally. The inclusion criteria for excitatory synapses included the presence
of pre- and post-synaptic membranes with a discernible synaptic cleft,
presence of asymmetric pre- and post-synaptic densities, and presence
of synaptic vesicles at the presynaptic terminal as described previously
(DeFelipe et al., 1999; Mayhew, 1996). Pre- and post-synaptic densities
from quantiﬁed synapses were measured for synaptic area and length
using ImageJ.
2.5. Western blot analyses
Ipsilateral hippocampal tissues from sham and CCI injured mice
were homogenized in RIPA bufferwith protease and phosphatase inhib-
itor cocktail (Sigma-Aldrich, St. Louis, MO) and benzonase nuclease
(Millipore Corporation, Billerica, MA) and mixed by rocking at 4 °C for
at least 15 min. Tissues were centrifuged, supernatant was recovered,
samples were diluted and standardized to protein concentrations. Pro-
tein samples were separated on 8–10% SDS-PAGE gel and transferred
to a nitrocellulose membrane. Membranes were then blocked with 5%
milk or 5% BSA in 0.1 M phosphate buffer with 0.1% Tween-20 for 1 h
at room temperature (RT) and incubated overnight at 4 °Cwith primary
antibodies. Membranes were incubated for 1 h at RT with HRP-conju-
gated secondary antibodies (Jackson Immunoresearch Laboratories,
West Grove, PA). Bands were visualized using SuperSignal substrate
(ThermoScientiﬁc, Pittsburg, PA). The following primary antibodies
were used: anti-GluR1, anti-NR1, anti-NR2B (EMD Millipore, Billerica,
MA), anti-GFAP (BD Biosciences, San Jose, CA), anti-SNAP25, anti-
SNAP23 (ABCAM, Cambridge, MA) and anti-β-tubulin (Sigma-Aldrich,
St. Louis, MO) antibodies. ImageJ was used to perform density analysis.
Protein measurements were standardized to β-tubulin and normalized
to average WT sham signals.
2.6. Intra-hippocampal infusion of ephrinB3
Alzet pumps (1003D, Alzet, Cupertino, CA) were preloaded with
112 μg/kg/day pre-clustered ephrinB3-Fc or Fc-only, while other exper-
iments used 840 μg/kg/day D-serine or vehicle. Brieﬂy, loaded pumps
were connected to a brain infusion catheter and placed in 0.1 M phos-
phate buffer at 37 °C overnight (Theus et al., 2014). After the CCI injury,
the infusion devicewas attached to the stereotactic holder and the tip of
the cannula was lowered 1.7 or 2.0 mm into the hippocampus or lateral
ventricle, respectively. The infusion device was secured to the skull
using Loctite 454 prism gel (Henkel Corp. Rocky Hill, CT). The pump
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was closed with suture. Mice were placed in clean heated cages to
recover.
2.7. Chemiluminescent assay
Mice were anesthetized and the ipsilateral hippocampi were imme-
diately dissected and homogenized in RIPA buffer with protease and
phosphatase inhibitor cocktail and benzonase nuclease and incubated
by rocking at 4 °C for at least 15min. Tissues were centrifuged, superna-
tants were recovered, and samples were diluted and standardized to
protein concentrations. D-serine was measured by a chemiluminescent
assay as previously described (Wolosker et al., 1999b; Zhuang et al.,
2010). A 10 μl sample was mixed with 100 μl of medium containing
100 mM Tris-HCl, pH 8.8, 20 units/ml peroxidase, and 8 μM luminol.
To decrease background signal of luminal, 10 μl of D-amino acid oxidase
(DAAO) (75 units/ml) were added after a 15 min delay. Chemilumines-
cence kinetics was recorded for 4 min at RTwith a FLUOstar Omegami-
croplate reader (BMG Labtech, Ortenberg, Germany). The concentration
of D-serine in each samplewas compared to a standard curve. The linear
range was 50–1000 pmol of D-serine in the sample and the detection
limit was 30 pmol. Glutamate was measured using Amplex Red
Glutamic Acid/Glutamate Oxidase Assay kit (Molecular Probes, Eugene,
OR) following the manufacturer's protocol. Fluorescence wasmeasured
in a FLUOstar Omega microplate reader using excitation in the range of
530–560 nm and emission detection at 590 nm. To correct for back-
ground ﬂuorescence, the values were subtracted from control well
values (i.e. no glutamic acid).
2.8. Electrophysiology
2.8.1. In vivo electrophysiology
Mice were anesthetized with urethane (1.5 g/kg) and placed on a
stereotaxic frame. A 25 μm concentric platinum-iridium bipolar stimu-
lation electrode and platinum-iridium recording electrode were
inserted through a craniotomy site at bregma: −2.0 mm; lateral:
−2.0 mm; depth: 1.4 mm (stimulation electrode) and bregma:
−1.8 mm; lateral:−1.4 mm; depth:−1 to−1.5 mm (recording elec-
trode). Concentric platinum-iridium bipolar stimulation electrodes (tip
diameter 25 μm, FHC, Bowdoin, ME) were placed in the Schaffer Collat-
erals and a recording glass micropipette ﬁlled with 150 mM sodium
chloride (1–3 MΩ) was placed in the CA1 stratum radiatum. Field po-
tentials were recorded and converted to digital using an Axoclamp 2B
ampliﬁer, Axon Instruments Digidata 1322A analog-to-digital convert-
er, and Clampex (Axon Instruments) software for data acquisition and
analysis. Input-output (I/O) curves were generated by delivering elec-
trical monophasic pulses to the CA3 Schaffer Collaterals from a Grass
S88 stimulator and S1U5 stimulus isolation unit, and measuring the
ﬁeld-excitatory post-synaptic potential (fEPSP) at increasing stimulus
intensities. Stimulus intensities were then adjusted to give fEPSP ampli-
tude at 45–55% of the maximum. A stable baseline fEPSP slope was re-
corded at a rate of 1/60 s for at least 30 min. A paired-pulse facilitation
protocol was run using inter-pulse intervals of 20 ms, 40 ms, and
80 ms. Long term potentiation (LTP) was induced with high-frequency
stimulation (HFS, 2 × 100 Hz, 1 s trains, 20 s inter-train interval).
Post-HFS fEPSPs were recorded for at least 60 min. Post-tetanus fEPSP
slopes were expressed as a percentage of the average fEPSP slope from
the baseline recordings.
2.8.2. In vitro electrophysiology
Mice were anesthetized using isoﬂurane and decapitated. Brains
rapidly removed, and to reduce tissue damage, were quickly immersed
in oxygenated ice-cold fresh high sucrose containing artiﬁcial cerebro-
spinal ﬂuid (high sucrose-aCSF): 100 mM sucrose, 60 mM NaCl, 3 mM
KCl, 1.25 mM NaH2PO4, 28 mM NaHCO3, 0.5 mM CaCl2, 7 mM MgCl2,
0.6 mM ascorbic acid, and 5 mM glucose equilibrated with 95% O2:5%CO2. Brains received a mid-sagittal hemisection and the ipsilateral hip-
pocampi were carefully dissected from the overlying cortex. The hippo-
campi were mounted on agarose blocks, and cross-sectioned into
300 μm slices with a motorized vibrating-blade microtome (Leica
VT1000s, Leica Biosystems Inc., Buffalo Grove, IL). Slices were gradually
transferred from high sucrose-aCSF to a holding chamber containing
50% high sucrose-aCSF/50% aCSF. aCSF contained: 125 mM NaCl,
2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 2 mM CaCl2, 1 mM
MgCl2, and 25mMglucose, oxygenatedwith 95% O2:5% CO2 at RT. Slices
were allowed to recover for at least 1 h in aCSF at RT before transfer to a
submersion-type recording chamber perfused with aCSF oxygenated
with 95% O2:5% CO2 at 32 °C. Field potentials were recorded using an
Axoclamp 2B ampliﬁer, Axon Instruments Digidata 1400 analog-to-dig-
ital converter, and Clampex software for data acquisition and analysis.
The recording protocolwas the sameasusedduring in vivo electrophys-
iological recordings.
2.9. Fear conditioning test
The fear conditioning apparatus consists of a box (30 × 24 × 21 cm,
Coulbourn Instruments, Whitehall, PA) with an electric grid ﬂoor
(0.8 cm spacing, 4.8 mm diameter rods). Mice were placed in the box
for habituation for 600 s. On the second day of the paradigm, mice
were placed back in the box for 120 s followed by a 30 s tone (85 dB,
2 kHz) with a 0.7 mA foot shock delivered through the grid ﬂoor during
the last 2 s of the tone. The animals remained in the box for an additional
60 s after the shock for a total duration of 210 s of training. At 24 h after
training, mice were placed in the same box and freezing behavior was
measured for 300 s to assess contextual fear conditioning. At 1 h after
contextual fear assessment, cue fear conditioning was assessed by plac-
ing mice in a chamber with different wall coloration, lighting and scent
and measuring freezing behavior for 360 s during which the tone
(85 dB, 2 kHz) was delivered for the last 180 s. The box was cleaned
with 70% EtOH and an enzymatic cleaner between animals. Freezing be-
havior was quantiﬁed using video-based analysis software
(FreezeFrame, Coulbourn Instruments, Whitehall, PA).
2.10. Statistical analyses.
Datawere graphed usingGraphPad Prism (GraphPad Inc., SanDiego,
CA). Comparisons between WT sham and EphB3−/− sham, WT sham
and WT CCI, or EphB3−/− sham and EphB3−/− CCI injured mice were
measured. Student's two-tailed t-test was used for comparison of two
experimental groups. One-way ANOVA or two-way ANOVA was used
for comparison of more than two groups, followed by Bonferroni post-
hoc correction. Kolmogorov-Smirnov (K-S) test was used to analyze
the distribution of synaptic density areas and width in combination
with Kruskal-Wallis test in the TEM studies. For hippocampal electro-
physiological recordings two-way ANOVA and repeated measures
ANOVA with Bonferroni post-hoc correction were used. Data is repre-
sented as mean value ± standard error of the mean (SEM).
3. Results
3.1. A CCI injurymodel to examine synaptic dysfunctionwithout hippocam-
pal neuronal loss
To examine the effects of traumatic brain injury (TBI) on synaptic
stability and function, we took advantage of a well-described controlled
cortical impact (CCI) injury model (Edward Dixon et al., 1991; Osier et
al., 2015; Smith et al., 1995; Theus et al., 2014). While other TBI models
exist, CCI injury allows for accurate replication of biomechanics similar
to human TBI (Peña et al., 2005; Xiong et al., 2013; Zhang et al., 2014),
and can be adapted to different injury severities depending on the ex-
perimental paradigm (BRODY et al., 2007; Chen et al., 2014; Saatman
et al., 2006; Assis-Nascimento et al., 2016). To examine synaptic
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controlled cortical impact (CCI) injury model where hippocampal syn-
aptic damage is independent of neuronal loss. Hematoxylin and eosin
(H&E) stained CCI injured wild type (WT) tissues showed substantial
cortical damage at 7 days post-CCI injury (dpi) as compared with
sham controls (Fig. 1A, B); however, no overt hippocampal damage
was observed (Fig. 1B) nor at 30 dpi (not shown). High magniﬁcation
of CA1 pyramidal neurons (CA1) of the hippocampus in Thy-1-YFP re-
porter mice also showed no visible neuronal damage at 7 dpi (Fig. 1A’,
B’). Furthermore, signiﬁcant upregulation in GFAP immunoreactivity
was observed in the CA1 hippocampus after CCI injury but not in
sham injured mice (Fig. 1C–D), which is consistent with activating hip-
pocampal injury cascades that lead to hypertrophic astrocytes but no
neuronal loss after brain injury (Burda et al., 2016; Chen et al., 2014;
Laird et al., 2008).
To determine whether CCI injury affects synaptic function at 7 dpi,
we measured CA3-CA1 hippocampal ﬁeld excitatory post-synaptic po-
tentials (fEPSPs) and long-term potentiation (LTP) in vivo. CCI injury
led to a signiﬁcant deﬁcit in synaptic recruitment at higher stimulus in-
tensities, as observed by a signiﬁcant difference in the input/output (I/
O) curve at stimulus intensities of 20 and 30 μA between sham and
CCI injured mice (p = 0.0313 and p = 0.0162, respectively; Fig. 1E).
In addition, examination of LTP showed a signiﬁcant reduction in the
CA3-CA1 fEPSP slope in CCI injured mice (p= 0.0132) when comparedFig. 1. CCI injury model of synaptic dysfunction without hippocampal neuronal losses. Hemato
and CCI (B) injury. Rectangles indicate region for images in A’–B’ and C–D. High magniﬁcation
densities in sham (A’) and CCI injured (B’) mice. Increased astrocyte (GFAP) reactivity and hy
(D) as compared with sham (C) mice. (E) Signiﬁcant downward shift in I/O curve of fEPSPs re
injured mice as compared with sham mice. Insets show sample fEPSP traces for I/O curve. (F
CCI injured mice, where fEPSP slopes were normalized to baseline. Inset depicts representat
Signiﬁcant decrease in percent freezing behavior in CCI mice compared with sham mice in b
from hematoxylin stained (H) and anti-NeuN immunoreactive (I) CA1, CA3, and DGC by no
***p b 0.001 compared with sham controls, ^^^p b 0.001 compared with habituation. Ctx,
dentate granule cells.with sham controls (Fig. 1F; n=4–5/group).We next examined hippo-
campal-dependent learning andmemory using a fear-conditioning par-
adigm known to detect deﬁcits after TBI (Titus et al., 2013). No
difference was observed in habituation and baseline training; however,
WT sham mice displayed signiﬁcant contextual and cued freezing be-
havior that was not observed in CCI injured mice (p b 0.001 and p =
0.0287, respectively; Fig. 1G; n = 7/group). Together, these ﬁndings
demonstrate that CCI injury results in signiﬁcant synaptic dysfunction
and learning deﬁcits even in the absence of gross hippocampal tissue
damage.
To evaluate whether synaptic deﬁcits are independent of hippocam-
pal cell loss or atrophy, we quantiﬁed the number of CA1 pyramidal
cells, CA3 pyramidal cells and dentate granule cells (DGC) at 7 dpi
using non-biased stereology on hematoxylin stained (Fig. 1H; n = 5/
group) and anti-NeuN immunolabeled (Fig. 1I; n = 3/group) hippo-
campal tissues in regions directly ventral to the injury epicenter. We
also performed tissue volume analysis at 7 dpi between groups using
non-biased stereology (SFig. 1A–D; n = 5/group). For all analyses, we
observed no signiﬁcant difference in the number or volume of CA1 or
CA3 pyramidal cells between sham and CCI injury. We did observe a
modest increase in DGC numbers after CCI injury as compared with
sham counterparts (p = 0.0324; Fig. 1H), but signiﬁcant difference
was not observed in the NeuN-positive cells (Fig. 1I), DGC or hilus vol-
umes (SFig. 1C, D). Quantitative differences between hematoxylin andxylin and eosin stained tissues showing gross morphological damage 7 dpi after sham (A)
confocal images of CA1 pyramidal neurons in Thy-1-YFP mice show neuronal dendritic
pertrophy, a hallmark of brain injury, is observed in the CA1 region of the after CCI injury
corded from CA1 stratum radiatum in vivo at increasing intensities of stimulation in CCI
) Tetanic high frequency stimulation (HFS) shows enhanced LTP in vivo in sham but not
ive pre- and post-HFS traces per group. E and F, sham n = 5 and CCI injury n = 4. (G)
oth contextual and cued testing (mean ± SEM; n = 7/group). Quantitative cell counts
n-biased stereology (n = 5/group). All data presented as mean ± SEM. *p b 0.05 and
cortex; Hipp, hippocampus; CA1, CA1 pyramidal cells; CA3, CA3 pyramidal cells; DGC,
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ously reported (Zhu et al., 2015), where hematoxylin counts where
based on morphological criteria while anti-NeuN counts were based
on nucleated anti-NeuN cell bodies. Together, these ﬁndings support a
CCI injury model where the mechanisms of synaptic damage can be ex-
amined independent of neuronal death.
3.2. EphB3 levels are increased after CCI injury
EphB3 signaling is known to have a deleterious effect in tissue recov-
ery (Theus et al., 2010, 2014); however, its effects on synaptic stability
and function after CCI injury are still poorly deﬁned. To evaluate the
role of EphB3 in the injured hippocampus, we ﬁrst examined EphB3
levels in the sham and CCI injured hippocampus at 3 and 7 dpi.Western
blot analysis showed a signiﬁcant increase in EphB3 levels at 3 and 7 dpi
as compared with sham controls (Fig. 2A; n = 4/group), which corre-
spond to the peak periods of synaptic dysfunction. In the absence of
EphB3 (i.e. EphB3−/−mice)we observed reduced gross cortical damage
at 7 dpi (Fig. 2C) as compared with WT CCI injury (Fig. 1B) and
EphB3−/− sham (Fig. 2B) mice, which supports previous ﬁndings
(Theus et al., 2014). In addition, no overt gross hippocampal damage
was observed and stereological quantiﬁcation of cell numbers showed
no differences in CA1 and CA3 pyramidal cell layers (Fig. 2D) or regional
hippocampal volumes between sham and CCI injured EphB3−/− mice
(SFig. 1A–D; n = 5/group). In the injured EphB3−/− hippocampal den-
tate gyrus (Fig. 2D), we did observe an increase in DGC numbers (p =
0.0324) similar to that observed in WT mice after injury (Fig. 1H).
3.3. CCI injury leads to EphB3-dependent synaptic loss in the hippocampus
To begin evaluating hippocampal synaptic damage following CCI inju-
ry, we used transmission electronmicroscopy (TEM) to quantify synaptic
numbers aswell asmeasured pre- and post-synaptic densities in the ipsi-
lateral CA1 stratum radiatum of WT and EphB3−/−mice at 7 dpi (Fig. 3;
n = 4/group). Tissues were cut into ultrathin sections (Fig. 3A), the CA1
was dissected and a placed on a grid (Fig. 3B), and non-overlapping pho-
tographs of EPTA-stained CA1 stratum radiatumwere taken (Fig. 3C).We
then quantiﬁed asymmetric (i.e. excitatory) synapses (Mayhew, 1996;
Sheng and Kim, 2011) if they met the following criteria: apposed pre-
andpost-synaptic densities, thepresence of pre-synaptic vesicles anda vi-
sually discrete synaptic cleft (Fig. 3D, E). WT CCI injured mice showed a
signiﬁcant ~20% reduction (p b 0.001) in synaptic numbers compared
with sham controls (Fig. 3F). We observed fewer synapses in EphB3−/−
sham mice than WT sham mice (p b 0.001; Fig. 3F), suggesting that
EphB3 may regulate synaptic formation or maintenance during develop-
ment. For this reason, CCI injury values were only compared to shamFig. 2. Increased levels of EphB3 does not affect cell survival in the hippocampus after CCI injury
mice,whichwere standardized toβ-tubulin and normalized to sham(mean±SEM;n=4/grou
sham (B) and CCI (C) injured tissue showing gross morphological damage. (D) Number of hipp
n = 5/group). *p b 0.05 and **p b 0.01.controls of their respective genotype. Interestingly,we did not observe in-
jury-induced synaptic losses in CCI injured EphB3−/−mice as compared
to EphB3−/− sham controls (Fig. 3F).
In addition to overt synaptic loss in WT mice, CCI injury could also
lead to disorganization of subsisting synapses, interruption of gluta-
matergic signaling scaffolds and impaired excitatory signaling (Carlson
et al., 2015; Luo et al., 2011, 2014). Thus, we next quantiﬁed the average
area of both pre- and post-synaptic density (SD) at 7 dpi in sham and
CCI injured WT and EphB3−/−mice. We observed no signiﬁcant differ-
ence in the area of pre-SD and post-SD between WT sham and CCI in-
jured mice (Fig. 3G, H), suggesting that remaining synapses are
possibly stabilizedwithin theﬁrstweek.Wedid observe a signiﬁcant in-
crease (p b 0.001) in the post-SD area in EphB3−/− sham mice com-
pared with WT sham mice (Fig. 3G). However, in the hippocampus of
EphB3−/−mice, CCI injury lead to signiﬁcantly less (p = 0.0023) area
covered by the post-SD protein network in the absence of synaptic
loss (Fig. 3G), suggesting that EphB3 may play deleterious roles in syn-
aptic maintenance after CCI injury.
To further evaluate synaptic densities, we examined the distribution
of synaptic density size between groups (Fig. 3I, J). Post-SD areas
showed a left-modal distribution that ranged from 0 to 11,000 nm2 for
sham-and CCI-injuredWT and EphB3−/− synapses (Fig. 3I). The overall
distribution of synaptic densities was evaluated using a Kolmogorov–
Smirnov (KS) test, which showed signiﬁcant variance between the dis-
tribution of WT versus EphB3−/− sham (p b 0.001) and between
EphB3−/− sham versus EphB3−/− CCI injured post-SD areas
(p b 0.001). However, no signiﬁcant differenceswere observed between
groups at any speciﬁc area using two-way repeated measures ANOVA.
Pre-SD areas also showed a left-modal distribution ranging from 0 to
5400 nm2 for sham- and CCI-injured WT and EphB3−/− synapses (Fig.
3J). KS tests did not show signiﬁcant difference between sham groups
or sham versus CCI injury within genotypes. These ﬁndings conﬁrm
that changes observed in pre- and post-SD areas (Fig. 3G–H) were due
to a shift in the overall sizes of the synaptic densities.
We also evaluated the variability in spine size based on average
post-SD diameters, which may differ from increased protein aggrega-
tion area (Martone et al., 1999). Examination of post-SD diameters
showed no difference in average diameter between groups (Fig. 3K);
however, analysis of cumulative distributions did show signiﬁcant dif-
ference between groups using KS test. Speciﬁcally, we observed a signif-
icant difference between EphB3−/− sham versus EphB3−/− CCI injury
(p = 0.0053). Two-way repeated measures ANOVA showed signiﬁcant
interactions between diameter and group, where the Bonferroni post-
hoc test showed signiﬁcant difference (p b 0.01) between EphB3−/−
sham and EphB3−/− CCI injury at diameters ranging between 0.21
and 0.25 μm (SFig. 2A).. (A)Western blots show increased hippocampal EphB3 protein levels at 3 and 7 dpi inWT
p, repeated in triplicate). For full blots see SFig. 4. Hematoxylin and eosin stained EphB3−/−
ocampal cells within each region in EphB3−/− sham and CCI injured mice (mean ± SEM;
Fig. 3. CCI injury leads to EphB3-dependent synaptic loss and alterations in pre- and post-synaptic densities in the hippocampus. (A) Cresyl violet stain of hippocampal tissue, where box
indicates regionwithin CA1 stratum radiatum selected for sectioning and grid placement. (B) Grid numbers represent random sampling ﬁelds for image acquisition (scale bar= 500 μM).
(C) Representative 25,000× electron micrograph of CA1 stratum radiatum with EPTA-stained excitatory synapses (scale bar = 50 μM). High magniﬁcation images of synapses with
asymmetrical pre- and post-SDs (D) and clear, delineated synaptic cleft and pre-synaptic vesicles (E). (F) CCI injury resulted in a reduction in synaptic numbers in WT, but not
EphB3−/− when compared with sham controls. (G) Quantiﬁcation of mean post-SD area showed EphB3−/− shams had increased post-SD area when compared with both WT sham
and EphB3−/− CCI group. (H) Quantiﬁcation of mean pre-SD area showed no difference between groups. Frequency distribution plots show positively-skewed curve of post-SD area
(I) and pre-SD area (J). (K) Quantiﬁcation of mean post-SD diameter showed no signiﬁcant differences between groups. (L) Comparison of the ratio between post-SD to pre-SD areas
showed opposing CCI injury-induced effects in WT and EphB3−/−mice, where CCI lead to an increase in WT ratio and decrease in EphB3−/− ratio. (M–P) Representative synapses for
each group reﬂect changes observed in synaptic quantiﬁcations. All data presented as mean ± SEM with n = 4/group with at least 20 micrographs per animal. *p b 0.05, **p b 0.01,
***p b 0.001 compared with WT sham, and ##p b 0.01; ###p b 0.001 compared with EphB3−/− sham.
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ship between post-SD and pre-SD areas (i.e. post-SD:pre-SD ratio),
since a synchronous change in spine size is necessary for enhancements
in synaptic strength (Meyer et al., 2014). We observed reversed trends
betweenWT and EphB3−/− ratios after CCI injury, where WT ratios in-
creased signiﬁcantly (p = 0.0084) while EphB3−/− ratios reduced sig-
niﬁcantly (p b 0.001) (Fig. 3L–P). Examination of cumulative
distributions showed group differences between WT sham versus
EphB3−/− sham (p = 0.0105), WT sham versus WT CCI injury (p =
0.0024), and EphB3−/− sham versus EphB3−/− CCI injury (p b 0.001).
Two-way repeated measures ANOVA of frequency distributions by
ratio size showed no signiﬁcant interaction between ratio and group
(SFig. 2B). These ﬁndings suggest that reduced synaptic function andbehavioral deﬁcits inWT CCI injuredmicemay be associatedwith over-
all synaptic loss as well as dysregulation of the synaptic unit within the
remaining synapses.
3.4. Absence of EphB3 signaling improves synaptic plasticity after CCI injury
To determine whether synaptic function is affected by the EphB3-
dependent ultrastructural changes after CCI injury, we examined CA3-
CA1 hippocampal ﬁeld excitatory postsynaptic potentials (fEPSPs) in
vivo in the presence and absence of EphB3 (Fig. 4; n = 4–6/group). To
assess basal synaptic transmission we recorded input-output (I/O)
curves at increasing stimulus intensities, and observed no signiﬁcant in-
teraction among animal groups and stimulus intensities (Fig. 4A);
Fig. 4. Synaptic plasticity is signiﬁcantly reduced in the hippocampus at 7 dpi inWT but not EphB3−/−mice. (A) I/O curve plotting the in vivo hippocampal fEPSP at increasing stimulus
intensities shows CCI injury in WT mice resulted in a signiﬁcant downward shift at higher stimulus intensities, while no signiﬁcant difference was observed in the EphB3−/− CCI group
when compared to EphB3−/− sham group. Inset, superimposed representative traces of evoked fEPSPs at increasing current intensities. (B) Examination of PPF, the ratio of second
fEPSP to the ﬁrst fEPSP slope, revealed no signiﬁcant differences between animal groups. (C) Examination of LTP, normalized to baseline fEPSP slope, in vivo at the CA1 hippocampal
synapse showed signiﬁcant CCI injury-induced deﬁcit in WT but not EphB3−/− mice. Analysis of fEPSP slope post-HFS revealed that injury resulted in signiﬁcant reductions in both
early (D) and late (E) phase LTP in WT CCI mice when compared with WT sham mice. No differences were observed between EphB3−/− sham and EphB3−/− CCI-injured mice for
either early or late LTP responses. All data presented as mean ± SEM. WT sham, n = 5; WT CCI, n = 4; EphB3−/− sham, n = 6; EphB3−/− CCI, n = 5. *p b 0.05, **p b 0.01 compared
with WT sham.
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ent stimulus intensities (p b 0.0001) and between animal groups (p =
0.0132). As we observed in our initial characterization of our CCI injury
model, WTmice subjected to CCI injury exhibit a signiﬁcant downward
shift in the I/O curve at higher stimulus intensities. Conversely,whenwe
measured the I/O curves in EphB3−/−mice, we observed no signiﬁcant
difference in synaptic recruitment after CCI injury compared to sham
(Fig. 4A). Examination of paired pulse facilitation (PPF), a measure of
presynaptic function, revealed no signiﬁcant differences between ani-
mal groups (Fig. 4B). These ﬁndings are consistentwith our in vitro hip-
pocampal slice recordings (SFig. 3A) and corroborate our ultrastructural
data that the effects observed after CCI injury are mainly post-synaptic
in nature. Finally, examination of long-term potentiation (LTP) in vivo
at the CA1 hippocampal synapse showed a signiﬁcant interaction be-
tween animal group and time (p b 0.0001) and main effect for animal
groups (p = 0.0131) and time (p b 0.0001) (Fig. 4C). Analysis of fEPSP
slope post-HFS (high frequency stimulation) revealed signiﬁcant reduc-
tions in both early and late LTP inWT CCI injuredmice (p= 0.0075 and
p = 0.0064, respectively) that were not observed in EphB3−/− CCI in-
jured mice when compared to genotype-matched shams (Fig. 4C–E).
Similarly, recordings from hippocampal slices harvested at 7 dpi from
CCI injuredWTmice showed reductions in fEPSP slope, but not in slices
from CCI injured EphB3−/−mice (SFig. 3B–D). These ﬁndings support a
deleterious role of EphB3 in synaptic function after CCI injury.Fig. 5. Hippocampal learning is signiﬁcantly reduced at 7 dpi in WT but not EphB3−/−
mice. Hippocampal-dependent fear-conditioning behavior quantiﬁed as percent freezing
showed no signiﬁcant differences between sham and CCI and between genotypes at
baseline; however, a signiﬁcant decrease in freezing behavior in both contextual and
cued learning was observed in WT CCI mice when compared with WT sham mice. Non-
signiﬁcant reductions were observed in EphB3−/− CCI injured mice compared to
EphB3−/− sham mice in both contextual and cued learning. Data presented as mean ±
SEM. WT sham, n = 10; WT CCI, n = 15; EphB3−/− sham, n = 10; EphB3−/− CCI, n =
8. ***p b 0.001 compared with WT sham.3.5. Absence of EphB3 signaling results in improved hippocampal learning
after CCI injury
We next examined hippocampal-dependent learning and memory
using a fear-conditioning paradigm. Following injury, WT and
EphB3−/− mice were habituated at 5 dpi, trained at 6 dpi and tested
for freezing behavior at 7 dpi. No signiﬁcant differences were observedbetween sham and CCI or between genotypes during training periods
(Fig. 5; n = 8–15/group). During the contextual testing period, we ob-
served a main effect for animal groups (p b 0.0001). CCI injury led to a
signiﬁcant (p b 0.0001) ~50% reduction in contextual and cued freezing
behavior in WT CCI injured mice when compared with WT sham mice.
Contrarily, EphB3−/− CCI injured mice performed statistically similar
to sham controls in both contextual and cued learning paradigms, al-
though a trend towards reduced performance after injurywas observed,
possibly due to extra-hippocampal damage following CCI injury. These
ﬁndings support our electrophysiological recordings that suggest acti-
vation of EphB3may exacerbate injury-induced deﬁcits in hippocampal
function.
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proteins
To investigate themolecular basis of the changes in synaptic plastic-
ity observed in CCI-injured hippocampal neurons in the presence and
absence of EphB3, we examined the expression of key synaptic proteins
essential for excitatory synaptic transmission. Speciﬁcally, we quanti-
ﬁed protein levels for post-synaptic glutamatergic receptor subunits
(i.e. GluR1, NR1 and NR2B) and synaptosomal-associated protein-23
(SNAP23) and -25 (SNAP25) in sham and CCI injured whole hippocam-
pal tissues at 7 dpi usingWestern blot analysis (Fig. 6; n=4/group).We
observed stable levels of the AMPAR subunit GluR1 regardless of geno-
type or injury state (Fig. 6A). The NMDAR subunits NR1 and NR2B con-
tribute to hippocampal learning and memory as well as injury-induced
excitotoxicity (Gambrill and Barria, 2011; Paoletti et al., 2013). NR1 sub-
units, the site for D-serine binding, showed no signiﬁcant differences
from sham controls for either genotype (Fig. 6B). In WT mice we ob-
served a signiﬁcant increase in NR2B levels after CCI injury (p =
0.0293) that was also observed in EphB3−/− mice as compared with
their respective sham controls (p = 0.0159) (Fig. 6C). We also exam-
ined SNARE complex proteins, SNAP-25 and SNAP-23, involved in neu-
ronal and astrocytic vesicular release, respectively. We did not observe
signiﬁcant differences in SNAP-25 nor SNAP-23 levels after CCI injury
for either WT or EphB3−/− mice (Fig. 6D, E). Finally, since increased
glial ﬁbrillary acidic protein (GFAP) levels are a hallmark of reactive
astroctyes after brain injury, we examined whether WT and EphB3−/−
mice showed differences in GFAP expression at 7 dpi. Similar increases
in GFAP immunoreactivity were observed between WT (p = 0.0003)
and EphB3−/− (p = 0.0002) mice (Fig. 6F). Together, these ﬁndings
suggest that signiﬁcant variances in core synaptic proteins do not un-
derlie the functional differences observed between WT and EphB3−/−
mice after CCI injury.Fig. 6. CCI-induced alterations in synaptic protein levels are similar inWT and EphB3−/− hippoc
SNAP-25 (D) and SNAP-23 (E), but NR2B (C) was upregulated in bothWT and EphB3−/−mice.
differences between WT and EphB3−/− CCI groups. Insets, representative Western blots for e
presented as mean ± SEM; n = 4/group, repeated in triplicate. *p b 0.05, **p b 0.01, ***p b 0.03.7. EphB3 regulates D-serine but not glutamate levels after CCI injury
We had previously shown that EphB3 can regulate D-serine levels in
the naïve brain (Zhuang et al., 2010), while others have shown D-serine
can exacerbate excitotoxic effects of NMDA hyper-activation after inju-
ry (Katsuki et al., 2004; Shleper et al., 2005). Therefore, we analyzed
transmitter levels in sham and CCI injured whole hippocampi in the
presence and absence of EphB3 using a chemiluminescent assay
(Fig.7; n=6–7/group). In theWThippocampus during the acute CCI in-
jury period, the D-serine levels increased at 4 and 24 h post-CCI injury
(hpi) as compared with sham controls (p = 0.0032 and p = 0.034, re-
spectively; Fig. 7A), but returned to baseline by 3 dpi and were main-
tained for at least 7 dpi (not shown). Examination of glutamate levels
at the same time points showed no signiﬁcant difference in WT CCI in-
jured tissues compared to WT sham controls (Fig. 7B), and these basal
levels were also maintained for at least 7 dpi (not shown). When we
compared the level of D-serine in EphB3−/− shams, we observed no sig-
niﬁcant difference from WT shams. Strikingly, in the CCI injured
EphB3−/− hippocampus, D-serine levels were not increased at 4 and
24 hpi (Fig. 7A).
Next, we examined whether ephrinB3 stimulation of Eph signaling
would augment D-serine or glutamate levels in WT mice at 3 dpi, a
timewhen transmitter levels have returned to baseline. Infusion of clus-
tered ephrinB3-Fc (112 μg/kg/day) for 3 days into the ipsilateral hippo-
campus resulted in a signiﬁcant increase in D-serine levels in
hippocampi fromWTmice but not EphB3−/−/EphA4−/− double knock-
out mice (Fig. 7C). EphB3−/−/EphA4−/−mice where used to eliminate
potential off target interactions with ephrinB3. Control anti-human-Fc
molecules showed no effect on D-serine levels as compared to non-in-
fused naïve or sham mice. Furthermore, application of clustered
ephrinB3-Fc did not alter glutamate levels in either WT or EphB3−/−/
EphA4−/−mice (Fig. 7D).ampi at 7 dpi. CCI injury did not result in signiﬁcant changes in levels of GluR1 (A), NR1 (B),
(F) GFAP, a marker of reactive astrocytosis, was signiﬁcantly upregulated after CCI with no
ach protein, including beta-tubulin as a loading control. For full blots see SFig. 4. All data
01 compared with sham control.
Fig. 7. Eph receptor signaling regulates injury-induced changes in D-serine but not glutamate levels in the hippocampus. CCI injury lead to signiﬁcant increases in total levels of D-serine in
WT but not EphB3−/− hippocampi at 4 and 24 hpi (A), while no signiﬁcant changeswere observed in total glutamate levels (B) at these time points. EphrinB3 stimulation of Eph signaling
lead to increased levels of D-serine in WT but not EphB3−/−/EphA4−/−mice at 3 dpi (C), while having no effect on levels of glutamate in both groups of mice (D). All data presented as
mean ± SEM; A, n = 7/group; B, n = 6/group; C, n = 7/group; D, n = 6/group. *p b 0.05, **p b 0.01, ***p b 0.001 compared with WT sham.
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served in EphB3−/−mice after CCI injury
To validate our conclusion that CCI injury-induced synaptic dysfunc-
tion is aggravated by EphB3 regulation of D-serine levels, we examinedFig. 8. Infusion of D-serine can reverse the enhanced synaptic plasticity observed in EphB3−/−
infusion in EphB3−/−mice, as seen by downward shift in I/O curve in current intensities of 2
current intensities. (B) Examination of presynaptic function through PPF revealed no signiﬁca
in D-serine- versus vehicle-treated EphB3−/−mice. Examination of LTP in vivo at the CA1 hipp
infused EphB3−/− mice (C). Analysis of fEPSP slope post-HFS revealed that injury resulted
EphB3−/− mice when compared with vehicle-infused EphB3−/− mice. All data presented
**p b 0.01, ***p b 0.001 compared with vehicle-infused group.CA3-CA1 hippocampal fEPSPs in vivo in CCI injured EphB3−/− mice
after vehicle or D-serine (840 μg/kg/day) infusion (Fig. 8; n = 6/
group). We infused D-serine or vehicle into the contralateral ventricle
for 3 days after CCI injury. EphB3−/−mice that received D-serine infu-
sion demonstrated reduced basal synaptic transmission revealed by amice at 7 dpi. (A) Basal synaptic transmission is diminished after D-serine but not vehicle
0 mA or higher. Inset, superimposed representative traces of evoked fEPSPs at increasing
nt differences between animal groups. (C–E) A signiﬁcant reduction in LTP was observed
ocampal synapse showed a signiﬁcant injury-induced deﬁcit in D-serine but not vehicle-
in signiﬁcant reductions in both early (D) and late (E) phase LTP in D-serine infused
as mean ± SEM; EphB3−/− CCI + vehicle, n = 6; EphB3−/− CCI + D-serine, n = 6.
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compared with vehicle-infused controls (Fig. 8A). Two-way repeated
measures ANOVA showed signiﬁcant interaction between groups and
stimulus intensity (p b 0.0001), where the Bonferroni post-hoc test
showed signiﬁcant difference between CCI injured EphB3−/− vehicle-
and D-serine-treated mice (p b 0.001). No signiﬁcant differences were
observed in PPF between groups (Fig. 8B); however, signiﬁcant differ-
enceswere observed in LTP. Speciﬁcally, we observed a signiﬁcant inter-
action between groups and time (p b 0.0001) andmain effect for animal
groups (EphB3−/− CCI-injured vehicle- vs. D-serine-infused; p =
0.0087) and time (p b 0.0001) (Fig. 8C). Analysis of fEPSP slope post-
HFS revealed that D-serine infusion resulted in signiﬁcant reductions
in both early and late LTP in EphB3−/−CCI injuredmicewhen compared
with vehicle-infused mice (p b 0.0001; Fig. 8C–E). These ﬁndings sup-
port our observations that increased D-serine levels in the hippocampus
are detrimental to synaptic function, and that EphB3 signalingmay reg-
ulate synaptic dysfunction after CCI injury through enhanced D-serine
synthesis and release.
4. Discussion
Synaptic dysfunction and impaired plasticity can have a signiﬁcant
impact on motor, sensory and cognitive functions in TBI patients. Neu-
ronal cell death is a predominant underlying cause for synaptic loss in
regions of tissue damage; however, synaptic dysfunction is also present
in more distal brain regions where neuronal loss is not observed (Lyeth
et al., 1990). To begin to examine synaptic dysfunction within the com-
plex and evolving TBI environment, we have developed a moderate CCI
injury model that leads to hippocampal synaptic damage without neu-
ronal losses. We then examined the role of ephrins and Eph receptors
in synaptic stability and function after TBI. In the CCI injured hippocam-
pus, we found that EphB3−/−mice showed stable numbers of synapses
compared to sham controls, and improved synaptic plasticity and learn-
ing behavior as comparedwithWT CCI injuredmice. Comparison of key
synaptic proteins essential for excitatory synaptic transmission showed
no differences betweenWT and EphB3−/−mice; however, increases in
the NMDAR co-agonist D-serine following CCI injury were signiﬁcantly
reduced in the absence of EphB3. Furthermore, rescuing D-serine levels
in EphB3−/−mice could recapitulate the synaptic deﬁcits observed in
WT CCI injured mice. These ﬁndings suggest that elevated D-serine
levels in the hippocampus may play deleterious roles by destabilizing
synapses after TBI, and are in part regulated by ephrin-EphB3 signaling.
Our observation that CCI injury results in approximately 20% synap-
tic losses, and N50% reduction in LTP and learning in the ﬁrst week sug-
gests that synaptic loss and dysfunction together may underlie the
observed functional deﬁcits. Our observed losses in excitatory synapses
in the mouse hippocampus are less pronounced than the ~50% reduc-
tion in CA1 synapses in rats after CCI injury (Scheff et al., 2005). This dis-
crepancy could be attributed to species-speciﬁc effects but also a higher
injury severity, which also lead to CA3 pyramidal cell death. Alternative-
ly, changes in synaptic size and morphology may also contribute to
functional deﬁcits (Carlson et al., 2015; Gao et al., 2011; Marrone et
al., 2004). After injury the main difference observed was an increase in
the ratio between post-SD to pre-SD area in WT mice. This could be
due to spine enlargement, a reduction of presynaptic bouton size, or a
combination of both. However, the opposite effect was observed in
the synaptic unit of EphB3−/−mice after injury. When taken together
with the deﬁcits in hippocampal function observed, these ﬁndings sug-
gest that synchronous changes in both elements of synapsemorphology
are important for structural stabilization and plasticity (Meyer et al.,
2014). Furthermore, excess activation by increased levels of D-serine
could be participating in destabilizing the synapse and causing synaptic
damage (Shleper et al., 2005).
Alterations in the levels of different synaptic proteins have also been
associated with deﬁcits in synaptic plasticity after TBI (Osteen et al.,
2004; Spaethling et al., 2012; Titus et al., 2013). The co-agonist bindingsite for D-serine is located on NR1 subunits (Johnson and Ascher, 1987;
Mothet et al., 2000). Interestingly, NR1 protein levels did not change
after CCI injury for either group, suggesting that increase in D-serine
after injury leads to increase binding probability (Furukawa and
Gouaux, 2003) and could enhanceNMDA-dependent glutamatergic sig-
naling. In the CCI injured hippocampus, we observed increased levels of
the NR2B subunit of the NMDAR in bothWT and EphB3−/−mice, which
has been shown to be associated with extra-synaptic NMDARs and the
detrimental effects of NMDAR over-activation (Bading et al., 1993;
Hardingham and Bading, 2010; Hardingham et al., 2002). Regulation
of NMDARs after injury seems to be temporally dependent and differs
between injury models (Giza et al., 2006; Hsu et al., 1998; Kumar et
al., 2002; Osteen et al., 2004; Schumann et al., 2008; Small et al.,
1997). In more severe models, an acute transient reduction in NR2B
levels is followed by protein up-regulation at later periods (Brown et
al., 2004; Kumar et al., 2002), while no difference is observed in less se-
vere models (Giza et al., 2006; Osteen et al., 2004). Despite these dis-
crepancies, a shift in the relative amounts of synaptic NR2A to extra-
synaptic NR2B receptors has been well established to mediate damage
caused by initial injury (Giza et al., 2006; Osteen et al., 2004; Small et
al., 1997), and likely contributes to the CCI injury-induced deﬁcits ob-
served in WT mice. However, increased NR2B receptors in EphB3−/−
mice did not result in synaptic damage or loss, suggesting that reduc-
tions in theNMDAR co-agonist D-serine likely underlie the reduced syn-
aptic damage observed in these mice. EphB receptors have been shown
to play roles in glutamate receptor activation, trafﬁcking and localiza-
tion (Antion et al., 2010; Grunwald et al., 2004; Henderson et al.,
2001; Irie et al., 2005). We cannot rule out that in EphB3 deﬁcient
mice NR2B receptors may remain in the cytoplasm, are unable to be-
come incorporated into the extra-synaptic membranes and do not con-
tribute to detrimental effects of over-activation.
Since our model of CCI injury did not involve hippocampal neuron
loss, it suggests that neuronal excitotoxicitymay be below the apoptotic
threshold in the hippocampus. It is well accepted that glutamate
excitotoxicity results from an acute release of glutamate from neurons
within the ﬁrst minutes after trauma, and leads to excessive calcium in-
ﬂux through over-activation of NMDARs, initiation of pro-apoptotic sig-
naling cascades, and ultimately neuronal damage (Faden et al., 1989;
Obrenovitch and Urenjak, 1997). While this likely occurs in the cortex
in our model, we did not observe neuronal loss in the hippocampus
even at regions directly ventral to the injury epicenter. Furthermore,
there was no signiﬁcant difference in total hippocampal glutamate
levels at 4 h post-injury (hpi), a time-point where glutamate levels
have returned to baseline (Obrenovitch andUrenjak, 1997) and the ear-
liest time-point we tested. Conversely, the NMDAR co-agonist D-serine
is up-regulated hours to days after CCI injury and contributes to synaptic
damage but not cell death. Enhanced D-serine levels have also been ob-
served in other peripheral and CNS injurymodels (Lin et al., 2015;Moon
et al., 2015). Moreover, pharmacological reductions in D-serine levels
have been shown to protect neurons from excitotoxic insult (Hama et
al., 2006; Shleper et al., 2005). In the absence of EphB3, increased D-ser-
ine levels were not observed after CCI injury. This provides support to
our previous gain-of-function studies showing that ephrinB3 stimula-
tion of EphB3 could increase D-serine levels in hippocampal slices and
cultured astrocytes (Zhuang et al., 2010). Excessive D-serine levels can
induce synaptic damage and reverse the rescue effects associated with
the absence of EphB3 after CCI injury; however, the addition of D-serine
by itself was not sufﬁcient to induce NMDA-mediated synaptic damage
in hippocampal slices (Katsuki et al., 2004). Together, these ﬁndings
support a role for EphB3 signaling in regulating D-serine levels as a
novel mechanism by which EphB3 receptors can potentiate damage in
the traumatic injured brain. Additional studies are needed to determine
how these effects are mediated by EphB3 signaling and establish if D-
serine release is from neurons and/or astrocytes.
TBI patients typically live with life-long cognitive impairment even
in the absence of signiﬁcant tissue pathology (Barth et al., 1983;
83E.J. Perez et al. / Neurobiology of Disease 94 (2016) 73–84Gualtieri and Cox, 1991; McAllister et al., 1999). To date, most neuro-
protective strategies have focused on preserving cell survival,
preventing glutamate excitotoxicity, and inhibiting secondary inﬂam-
matory responses (Beauchamp et al., 2008; Corps et al., 2015). Our ﬁnd-
ings suggest that synaptic loss and dysfunction may be an important
therapeutic target. Understanding the mechanisms regulating D-serine
and NMDARs contributing to the balance of synaptic stability versus
dysfunction will have important neuroprotective consequences. Our
study suggests Eph receptor signaling plays a role in regulating this bal-
ance, whereby inhibiting Eph receptor signaling could lead to improved
synaptic numbers and function after TBI.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nbd.2016.06.007.
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